
TNDM Stock Forecast & Price Target
TNDM Analyst Ratings
Bulls say
Tandem Diabetes Care is well positioned with multiple innovative products, including t:slim X2, Mobi, and Sigi tubeless patch pump. The company has a strong potential for growth with its multi-year runway, high demand for its products in both Type 1 and Type 2 markets, and its target market of 11 million people with diabetes. Its recent shift to the pharmacy channel is also expected to drive growth and profitability.
Bears say
Tandem Diabetes Care is facing several risks, including potential competition from other companies and challenges in retaining its customer base. Despite its recent success in introducing new products, uncertainties remain in its ability to expand in both domestic and international markets. Additionally, its dependence on third-party suppliers and the potential negative impact of reimbursement issues could impact its financial performance.
This aggregate rating is based on analysts' research of Tandem Diabetes Care and is not a guaranteed prediction by Public.com or investment advice.
TNDM Analyst Forecast & Price Prediction
Start investing in TNDM
Order type
Buy in
Order amount
Est. shares
0 shares